|
简单计算复星医药持有上市公司的股权价值
| 序号 |
上市公司 |
持股比例 |
复星拥有市值 |
投资成本 |
|
| 公司名 |
股本 |
股价(人民币) |
市值 |
|
| 1 |
滨化股份 |
66,000 |
17.87 |
1,179,420 |
7.50% |
88,457 |
14,535 |
|
| 2 |
羚锐制药 |
20,072 |
13.13 |
263,545 |
0.59% |
1,555 |
219 |
|
| 3 |
海翔药业 |
16,050 |
24.55 |
394,028 |
3.72% |
14,658 |
1,692 |
|
| 4 |
汉森制药 |
14,800 |
23.12 |
342,176 |
14.86% |
50,847 |
4,860 |
|
| 5 |
水晶光电 |
11,565 |
36.79 |
425,476 |
9.90% |
42,122 |
1,865 |
|
| 6 |
东富龙科技 |
16,000 |
43.85 |
701,600.00 |
7.50% |
52,620 |
4,000 |
|
| 7 |
金城医化 |
12,100 |
21.42 |
259,182.00 |
14.88% |
38,566 |
5,200 |
|
| 8 |
佰利联 |
9,400 |
124.75 |
1,172,650.00 |
10.64% |
124,770 |
5,300 |
|
| 9 |
迪安诊断 |
5,110 |
38.15 |
194,946.50 |
10.57% |
20,606 |
3,214 |
|
| 10 |
民生银行 |
|
5.62 |
|
|
3,260 |
3,004 |
|
| 11 |
西安隆基硅材料 |
|
|
|
|
|
13,800 |
|
| 12 |
青岛亨达 |
|
|
|
|
|
11,853 |
|
| 13 |
安徽山河药辅 |
|
|
|
|
|
2,352 |
|
| 14 |
颈复康 |
|
|
|
|
|
12,000 |
|
| 15 |
持有国内A股市值小计 |
|
|
437,460 |
83,894 |
|
| 16 |
国药控股 |
240,262 |
20.4 |
4,901,345 |
32% |
1,570,881 |
|
|
| 17 |
|
|
|
|
|
|
|
|
| 18 |
先声药业 |
|
|
#DIV/0! |
|
5,796 |
14,327 |
|
| 19 |
东瑞制药 |
191,146 |
2.16 |
412,876 |
1.53% |
6,317 |
10,778 |
|
| 20 |
中生北控 |
13,130 |
2.97 |
38,996 |
23.83% |
9,293 |
6,463 |
|
| 21 |
持有港股市值 |
|
|
21,406 |
25,105 |
|
| 22 |
美中互利 |
|
|
|
19.16% |
|
30,024 |
|
| 23 |
同济堂 |
|
|
|
32.10% |
|
18,591 |
|
| 24 |
持有国外股市值 |
|
|
|
|
|
| 25 |
天药股份 |
54,300 |
9.33 |
506,619.00 |
11.71% |
59,312 |
|
|
| 26 |
利尔化学 |
20,244 |
15.38 |
311,352.72 |
4.82% |
15,021 |
|
|
| 27 |
中环股份 |
72,424 |
21.23 |
1,537,561.52 |
4.07% |
62,617 |
|
|
| 28 |
间接持股市值 |
|
136,950 |
|
|
| 29 |
合计 |
|
|
|
|
2,166,698 |
27,171 |
|
|
|
|
|
|
|
|
|
|
|
注：1、利尔化学由中通投资持股25.73%，天津药业持有中通投资75%股份，复星医药持有天津药业25%股份 |
|
2、中环股份由天津药业持有16.29%股份 |
|
|
